According to the World Health Organization (WHO), the new classification of lymphomas is mainly based on morphological, immunophenotypical, and molecular criteria. Consequently, this new approach has led from the substantial role that architecture played in the past to a secondary panel highlighting the role of fine-needle biopsy (FNB). Applied together with other ancillary techniques, such as flow cytometry (FC), FNB is a potential tool for the diagnosis of lymphomas, and enlarged lymph nodes represent an excellent target for the implementation of this technique. Despite the difficulties inherent in this technology, which might pose problems in differential diagnosis, in the majority of cases this joint work allows an accurate diagnosis of malignancy and even correct subcharacterization in routine lymphomas. Additionally, in selected cases, other molecular techniques like FISH and PCR can also be performed on FNB specimens, helping in the characterization and diagnosis of lymphomas. In this review, we discuss the basic aspects of the combination of FNB cytology and FC in the diagnosis and subclassification of lymphomas. The preanalytical phase is extensively discussed. The advantages, disadvantages, and technical limitations of this joint work are addressed in general and in terms of the accurate subclassification of lymphomas.

Keywords:
Flow cytometry, Lymph node, Lymphoma, Fine needle biopsy, Cytology
1.
Swerdlow SH, Campo E, Harris NL, et al: WHO classification of haematopoietic and lymphoid tissues. Lyon, IARC Press, 2008.
2.
Zeppa P, Sosa Fernandez LV, Cozzolino I, Ronga V, Genesio R, Salatiello M, Picardi M, Malapelle U, Troncone G, Vigliar E: Immunoglobulin heavy-chain fluorescence in situ hybridization-chromogenic in situ hybridization DNA probe split signal in the clonality assessment of lymphoproliferative processes on cytological samples. Cancer Cytopathol 2012;120:390-400.
3.
Kocjam G: Cytological and molecular diagnosis of lymphoma. J Clin Pathol 2005;58:561-567.
4.
Cancer: New Registrations and Deaths. Wellington, Ministry of Health, 2010.
5.
Zeppa P, Marino G, Troncone G, Fulciniti F, De Renzo A, Picardi M, Benicasa G, Rotoli B, Vetrani A, Palombini L: Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma. Cancer Cytopathol 2003;102:55-65.
6.
Dong HY, Harris NL, Preffer FI, Pitman MB: Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: a retrospective analysis of the utility of cytomorphology and flow cytometry. Mod Pathol 2001;14:472-481.
7.
Meda BA, Buss DH, Woodruff RD, et al: Diagnosis and subclassification of primary recurrent lymphoma: the usefulness and limitations of combined fine-needle aspiration cytomorphology and flow cytometry. Am J Clin Pathol 2000;113:688-699.
8.
Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, et al: Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014;32:3059-3068.
9.
Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, Walewski J, André M, Johnson PW, Pfreundschuh M, Ladetto M; ESMO Guidelines Committee: Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26(suppl 5):v116-v125.
10.
Langerak AW, van Den Beemd R, Wolvers-Tettero IL, et al: Molecular and flow cytometry analysis of the Vβ repertoire for clonality assessment in mature TCRαβ T-cell proliferations. Blood 2001;98:165-173.
11.
Beck RC, Stahl S, O'Keefe CL, Maciejewski JP, Theil KS, Hsi ED: Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor Vβ antibodies. Am J Clin Pathol 2003;120:785-794.
12.
Fromm JR, Thomas A, Wood BL: Flow cytometry can diagnose classical Hodgkin lymphoma in lymph nodes with high sensitivity and specificity. Am J Clin Pathol 2009;131:322-332.
13.
Roshal M, Wood BL, Fromm JR: Flow cytometric detection of the classical Hodgkin lymphoma: clinical and research applications. Adv Hemathol 2011;2011:9.
14.
Das DK, Francis IM, Sharma PN, Sathar SA, John B, George SS, Mallik MK, Sheikh ZA, Haji BE, Pathan SK, Madda JP, Mirza K, Ahmed MS, Junaid TA: Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology. Diagn Cytopathol 2009;37:564-573.
15.
Irsch J, Nitsch S, Hansmann M-L, Rajewsky K, Tesch H, Dieh V, Jox A, Küppers R, Radbruch A: Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues. Proc Natl Acad Sci USA 1998;95:10117-10122.
16.
Caraway NP: Evolving role of FNA biopsy in diagnosing lymphoma: past, present, and future. Cancer Cytopathol 2015;123:389-393.
17.
da Cunha Santos G, Ko HM, Geddie WR, Boerner SL, Lai SW, Have C, Kamel-Reid S, Bailey D: Targeted use of fluorescence in situ hybridization (FISH) in cytospin preparations: results of 298 fine needle aspirates of B-cell non-Hodgkin lymphoma. Cancer Cytopathol 2010;118:250-258.
18.
Monaco SE, Teot LA, Felgar RE, Surti U, Cai G: Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. Cancer 2009;117:338-348.
19.
Jaffe ES, Banks PM, Nathwani B, et al: Recommendations for the reporting of lymphoid neoplasms: a report from the association of directors of anatomic and surgical pathology. Mod Pathol 2004;17:131-135.
20.
Zajdela A, Zillhardt P, Voillemot N: Cytological diagnosis by fine needle sampling without aspiration. Cancer 1987;59:1201-1205.
21.
Skoog L, Tani E: FNA Cytology in the Diagnosis of Lymphoma. Monogr Clin Cytol. Basel, Karger, 2009, vol 18, pp 5-10.
22.
Zardawi IM, Jain S, Bennett G: Flow cytometry algorithm on fine needle aspirates for clinical workup of patients with lymphadenopathy. Diagn Cytopathol 1998;19:274-278.
23.
Hirachand S, Lakhey M, Akhter J, Thapa B: Evaluation of fine needle aspiration cytology of lymph nodes in Kathmandu Medical College, Teaching Hospital. Kathmandu Univ Med J 2009;26:139-142.
24.
LeBien TW, Tedder TF: B lymphocytes: how they develop and function. Blood 2008;112:1570-1580.
25.
Brandao GD, Rose R, McKenzie S, Maslak P, Lin O: Grading follicular lymphomas in fine-needle aspiration biopsies: the role of Thin-Prep slides and flow cytometry. Cancer 2006;108:319-323.
26.
Young NA, Al-Saleem TI, Al-Saleem Z, Ehya H, Smith MR: The value of transformed lymphocyte count in subclassification of non-Hodgkin's lymphoma by fine-needle aspiration. Am J Clin Pathol 1997;108:143-151.
27.
van den Brand M, van Krieken JH: Recognizing nodal marginal zone lymphoma: recent advances and pitfalls - a systematic review. Haematologica 2013;98:1003-1013.
28.
Caraway NP: Strategies to diagnose lymphoprolioherative disorders by fine-needle aspiration by using ancillary studies. Cancer Cytopathol 2005;105:432-442.
29.
Ondrejka SL, Hsi ED: Pathology of B-cell lymphomas: diagnosis and biomarker discovery. Cancer Treat Res 2015;165:27-50.
30.
Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
31.
Cozzolino I, Varone V, Picardi M, Baldi C, Memoli D, Ciancia G, Selleri C, De Rosa G, Vetrani A, Zeppa P: CD10, BCL6 and MUM1 expression in diffuse large B-cell lymphoma on FNA samples. Cancer Cytopathol 2015;124:135-143.
32.
Hans CP, Weisenburger DD, Greiner TC, et al: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using tissue microarray. N Engl J Med 2002;103:275-282.
33.
Scott DW, Wright GW, Williams PM, Lih CJ, Walsh W, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Smeland EB, Mottok A, Braziel RM, Ott G, Delabie J, Tubbs RR, Cook JR, Weisenburger DD, Greiner TC, Glinsmann-Gibson BJ, Fu K, Staudt LM, et al: Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood 2014;123:1214-1217.
34.
Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES, Montes-Moreno S, Dybkær K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B cell lymphoma: a report from the international DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 2012;26:2103-2113.
35.
Rosario-Quinones F, Strauchen JA, Salem F: Anaplastic large cell lymphoma masquerading as classical Hodgkin lymphoma on fine needle aspiration. Diagn Cytopathol 2015;43:916-919.
36.
Chhabra S, Verma R, Jain P, Tayal M, Singh J, Sen R: Anaplastic large cell lymphoma: a cytological masquerade. Am J Med Case Rep 2015;3:247-249.
37.
EuroFlow: resetting leukemia and lymphoma immunophenotyping - basis for companion diagnostics and personalized medicine (editorial). Leukemia 2012;26:1899-1907.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.